Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000993525 | SCV001146568 | benign | not provided | 2019-03-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993525 | SCV001831757 | benign | not provided | 2019-09-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492538 | SCV002800449 | benign | Complex cortical dysplasia with other brain malformations 7 | 2021-12-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000993525 | SCV003246775 | uncertain significance | not provided | 2023-04-20 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TUBB2B protein function. ClinVar contains an entry for this variant (Variation ID: 160184). This variant has not been reported in the literature in individuals affected with TUBB2B-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 235 of the TUBB2B protein (p.Gly235Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |